ALS, also known as "Lou Gehrig's disease," is an incurable, degenerative neurological disorder. For reasons that are not understood, the nerve cells of the brain and spinal cord that control voluntary muscle movement gradually deteriorate. ALS can prove difficult to diagnosis because the initial symptoms are both subtle and vague, and can be attributed to a number of conditions. Average life expectancy after diagnosis ranges from 2 to 5 years. There are no known therapies to effectively halt the progression of ALS. Research supports a relationship between ALS and military service with a higher rate of incidence in the veteran population. In addition, 1990-1991 Gulf War veterans have been shown to be approximately twice as likely to develop ALS as veterans who had not served in the Gulf. Reasons for this incidence are not yet understood. The ALSRP focuses funding on translational research, with the specific goal of finding new treatments for our military men and women living with ALS and the thousands of other Americans whose lives continue to be impacted by this disease.
- $39.4 million FY07, FY09-13
- $7.5 million FY14
- 30 Awards in FY07, FY09-13
- Recent Applications Recommended for Funding